510(k) Report

510(k) · Cleared

Cleared

Amylase-Incorporating Dynamic Stabilization Technology - (DST)

K972297510(k) TraditionalCleared Jul 17, 199728-day reviewClass II21 CFR 862.1070

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Trace America, Inc. · JFJ Catalytic Methods, Amylase

Cleared on Jul 17, 1997 after a 28-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 12 later devices descend from it.

Decided
Jul 17, 1997
Review
28 days
Class
Class II
Product code
JFJ
Recalls
None
Predicates
0

12 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2007: 3 descendants cleared2012: 1 descendant cleared2011: 2 descendants cleared2013: 1 descendant cleared2008: 1 descendant cleared2021: 1 descendant cleared2019: 2 descendants cleared2015: 1 descendant cleared1995200020052010201520202025
  1. This deviceK972297 Amylase-Incorporating Dynamic Stabilization Technology - (DST)Trace America, Inc. · 1997
  2. Descendant · cites it directly · 11 of its ownK070249 Abx Pentra 400, Calcium CP, Creatinine CP, Phosphorus CP, Amylase…Horiba Abx · 2007 · Recalled
  3. Descendant · 2 generations on · 3 of its ownK070146 Abx Pentra Glucose HK CP, Urea CP, Uric Acid CPHoriba Abx · 2007
  4. Descendant · 2 generations on · 2 of its ownK123171 Abx Pentra Calcium as CP, Abx Pentra Urine Control L/H, Abx Pentra…Horiba Abx Sas · 2013
  5. Descendant · 3 generations on · 2 of its ownK081276 Abx Pentra Glucose HK CP, Abx Pentra Uric Acid CP, Abx Pentra Urine…Horiba Abx · 2008 · Recalled
  6. Descendant · 2 generations on · 1 of its ownK110530 Abx Pentra Creatinine 120 CP; Abx Pentra Multical; Abx Pentra N…Horiba Abx Sas · 2012 · Recalled

Showing 5 of 12 descendants. See all descendants

Descendants cleared per year

2007: 32008: 12011: 22012: 12013: 12015: 12019: 22021: 1
2007high 3 (2007) · low 0 (2009)2026

Most influential descendants

Showing 5 of 12 · See all
  • K070249Abx Pentra 400, Calcium CP, Creatinine CP, Phosphorus CP, Amylase CP, Urine Control L/HHoriba Abx · 2007 · cites it directly11descendants
  • K070146Abx Pentra Glucose HK CP, Urea CP, Uric Acid CPHoriba Abx · 2007 · 2 generations on3descendants
  • K123171Abx Pentra Calcium as CP, Abx Pentra Urine Control L/H, Abx Pentra Multical, Abx Pentra…Horiba Abx Sas · 2013 · 2 generations on2descendants
  • K081276Abx Pentra Glucose HK CP, Abx Pentra Uric Acid CP, Abx Pentra Urine Control L/HHoriba Abx · 2008 · 3 generations on2descendants
  • K110530Abx Pentra Creatinine 120 CP; Abx Pentra Multical; Abx Pentra N Control; Abx Pentra P…Horiba Abx Sas · 2012 · 2 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K972297Amylase-Incorporating Dynamic Stabilization Technology - (DST)Trace America, Inc.1997—
+1K070249Abx Pentra 400, Calcium CP, Creatinine CP, Phosphorus CP, Amylase CP, Urine…Horiba Abx20071
+2K070146Abx Pentra Glucose HK CP, Urea CP, Uric Acid CPHoriba Abx2007—
+2K123171Abx Pentra Calcium as CP, Abx Pentra Urine Control L/H, Abx Pentra Multical…Horiba Abx Sas2013—
+3K081276Abx Pentra Glucose HK CP, Abx Pentra Uric Acid CP, Abx Pentra Urine Control L/HHoriba Abx20081
+2K110530Abx Pentra Creatinine 120 CP; Abx Pentra Multical; Abx Pentra N Control; Abx…Horiba Abx Sas20123

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200730
200810
201120
201210
201310
201510
201920
202110
FIG. 1 — Lineage of K972297, 1997–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JFJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JFJ device

  1. #1 K210633 Amylase2score 3.7 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (12)

See all 12

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K070249Abx Pentra 400, Calcium CP, Creatinine CP, Phosphorus CP, Amylase CP, Urine Control L/HHoriba Abx200711

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K070249 (Horiba Abx, 2007) has gone furthest, with 11 descendants of its own.

How does its category compare?

All JFJ devices

JFJ Catalytic Methods, Amylase: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JFJ

1in 2022

2007: 12008: 12009: 12012: 12013: 12019: 22022: 1
2007high 2 (2019) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JFJ

Too few JFJ 510(k)s in any year since 2007 to give a median.

Recalls per year · JFJ

1in 2007

2007: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JFJ

1in 2025

2010: 12011: 22012: 12018: 22020: 12022: 12024: 12025: 1
2007high 2 (2011) · low 0 (2007)2025

MAUDE reports naming product code JFJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—10
20081—00
20091—00
20100—01
20110—02
20121—01
20131—00
20140—00
20150—00
20160—00
20170—00
20180—02
20192—00
20200—01
20210—00
20221—01
20230—00
20240—01
20250—01
20260—0—

What is it indicated for?

Intended for the In Vitro, quantitative determination of Amylase in human serum and urine for clinical diagnosis.

"This Amylase test system is a device intended to measure the activity of the enzyme amylase in serum, and urine. Amylase measurements are used primarily for the diagnosis and treatment of pancreatitis (inflammation of the pancreas)". , CFR 862.1070

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K972297: Amylase-Incorporating Dynamic Stabilization Technology - (DST).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K972297

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026